Athira Pharma to effect 10-for-1 reverse stock split on Sep 17 to meet Nasdaq minimum bid price

LeonaBio, Inc.

Effective Sept 17 at 5pm ET; shares start trading split-adjusted on Sep 18 under ticker ATHA.
Every 10 pre-split shares convert to 1; authorized common shares reduced from 900M to 90M.
Purpose: increase share price to comply with Nasdaq's $1.00 minimum bid requirement.
Fractional shares paid in cash; CUSIP changes to 04746L203.
No action needed by book-entry or street-name holders; Computershare is exchange agent.

item 3.03 item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LeonaBio, Inc.: Amended certificate of incorporation to effect a 10-for-1 reverse stock split (effective 2025-09-17).

Change: charter amendment
Effective: 2025-09-17

Exact text from the filing

On September 10, 2025, the Company filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware to effect a 10-for-1 reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share, effective as of 5:00 p.m., Eastern Time, on September 17, 2025 (the “Reverse Stock Split”).

View on SEC.gov

Browse all governance changes →

LeonaBio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-114093

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.